Pasquale Rescigno

8.1k total citations
82 papers, 1.3k citations indexed

About

Pasquale Rescigno is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Pasquale Rescigno has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 22 papers in Surgery. Recurrent topics in Pasquale Rescigno's work include Prostate Cancer Treatment and Research (39 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Cancer Genomics and Diagnostics (13 papers). Pasquale Rescigno is often cited by papers focused on Prostate Cancer Treatment and Research (39 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Cancer Genomics and Diagnostics (13 papers). Pasquale Rescigno collaborates with scholars based in Italy, United Kingdom and United States. Pasquale Rescigno's co-authors include Sabino De Placido, Johann S. de Bono, Giuseppe Di Lorenzo, Carlo Buonerba, Giovannella Palmieri, Sisto Perdonà, Piera Federico, Matteo Ferro, David Lorente and Michele Aieta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Pasquale Rescigno

74 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pasquale Rescigno Italy 22 773 397 381 317 230 82 1.3k
Tony Elliott United Kingdom 22 736 1.0× 213 0.5× 326 0.9× 503 1.6× 535 2.3× 58 1.6k
Guilhem Roubaud France 19 1.1k 1.4× 314 0.8× 439 1.2× 702 2.2× 281 1.2× 132 1.6k
Mario Eisenberger United States 14 981 1.3× 247 0.6× 234 0.6× 398 1.3× 142 0.6× 32 1.5k
Rosa Nadal United States 18 1.4k 1.8× 523 1.3× 472 1.2× 572 1.8× 261 1.1× 48 1.9k
Teodoro Sava Italy 18 554 0.7× 231 0.6× 292 0.8× 502 1.6× 282 1.2× 69 1.1k
Sebastian Rogenhofer Germany 22 1.0k 1.4× 381 1.0× 808 2.1× 267 0.8× 184 0.8× 40 2.0k
Carlo Messina Italy 23 540 0.7× 459 1.2× 374 1.0× 829 2.6× 401 1.7× 102 1.7k
Remedios Penetrante United States 19 498 0.6× 397 1.0× 442 1.2× 596 1.9× 352 1.5× 35 1.5k
Damien Pouessel France 20 790 1.0× 239 0.6× 377 1.0× 844 2.7× 638 2.8× 120 1.8k
Idris Tolgay Ocal United States 20 259 0.3× 378 1.0× 345 0.9× 416 1.3× 418 1.8× 53 1.5k

Countries citing papers authored by Pasquale Rescigno

Since Specialization
Citations

This map shows the geographic impact of Pasquale Rescigno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasquale Rescigno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasquale Rescigno more than expected).

Fields of papers citing papers by Pasquale Rescigno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pasquale Rescigno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasquale Rescigno. The network helps show where Pasquale Rescigno may publish in the future.

Co-authorship network of co-authors of Pasquale Rescigno

This figure shows the co-authorship network connecting the top 25 collaborators of Pasquale Rescigno. A scholar is included among the top collaborators of Pasquale Rescigno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pasquale Rescigno. Pasquale Rescigno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oing, Christoph, Christoph Seidel, Pasquale Rescigno, et al.. (2024). Hyperthyroidism in non-seminomatous testicular germ cell tumors: two case reports and literature review. Frontiers in Oncology. 14. 1338438–1338438. 1 indexed citations
2.
Fisher, Matthew, Mateus Crespo, Bora Gürel, et al.. (2024). Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy. Journal for ImmunoTherapy of Cancer. 12(7). e009368–e009368. 7 indexed citations
3.
Fratino, Lucia, Jerry Polesel, Emilio Francesco Giunta, et al.. (2024). Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study. Scientific Reports. 14(1). 4949–4949.
4.
Rebuzzi, Sara Elena, Giuseppe Fornarini, Marco Maruzzo, et al.. (2024). A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study. Immunotherapy. 16(14-15). 963–973. 2 indexed citations
5.
6.
Messina, Carlo, Emilio Francesco Giunta, Alessio Signori, et al.. (2023). Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis. European Urology Oncology. 7(2). 179–188. 22 indexed citations
7.
Rizzo, Alessio, Manuela Racca, Pasquale Rescigno, et al.. (2023). The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review. Cancers. 15(2). 355–355. 20 indexed citations
8.
Bauckneht, Matteo, Enrico Checcucci, Alessio Rizzo, et al.. (2023). The prognostic role of next-generation imaging-driven upstaging in newly diagnosed prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 51(3). 864–870. 19 indexed citations
9.
Rescigno, Pasquale, et al.. (2023). Basal cell carcinoma of the prostate: a case report of a rare prostate cancer and review of the literature.. PubMed. 94(S1). e2023232–e2023232.
10.
Cerbone, Luigi, Pasquale Rescigno, Fabio Catalano, et al.. (2022). Combined Response of Advanced Cutaneous Squamous Cell Carcinoma and Renal Cell Carcinoma to Immunotherapy: A Case Report. Immunotherapy. 14(18). 1419–1427.
11.
Conteduca, Vincenza, Alessandra Mosca, Nicole Brighi, Ugo De Giorgi, & Pasquale Rescigno. (2021). New Prognostic Biomarkers in Metastatic Castration-Resistant Prostate Cancer. Cells. 10(1). 193–193. 33 indexed citations
12.
Curcean, Andra, Pasquale Rescigno, Derfel ap Dafydd, et al.. (2021). Imaging features of the evolving patterns of metastatic prostate cancer. Clinical Radiology. 77(2). 88–95. 7 indexed citations
13.
Checcucci, Enrico, Stefano De Luca, Federico Piramide, et al.. (2021). The real-time intraoperative guidance of the new HIFU Focal-One® platform allows to minimize the perioperative adverse events in salvage setting. Journal of Ultrasound. 25(2). 225–232. 4 indexed citations
14.
Rodrigues, Daniel Nava, Nicola Casiraghi, Alessandro Romanel, et al.. (2018). RB1 Heterogeneity in Advanced Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 25(2). 687–697. 44 indexed citations
15.
Rescigno, Pasquale & Johann S. de Bono. (2018). Immunotherapy for lethal prostate cancer. Nature Reviews Urology. 16(2). 69–70. 19 indexed citations
16.
Barrero, Maialen, Mattia Rediti, Mateus Crespo, et al.. (2018). Tumor-infiltrating lymphocytes in biallelic-CDK12 mutated prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 5070–5070. 4 indexed citations
17.
18.
Nappi, Lucia, V. Damiano, Margaret Ottaviano, et al.. (2015). Correlation between plasmatic levels of vitamin D and testicular cancer. Annals of Oncology. 26. vi58–vi58. 3 indexed citations
19.
Rescigno, Pasquale, Carlo Buonerba, Joaquim Bellmunt, et al.. (2012). New Perspectives in the Therapy of Castration Resistant Prostate Cancer. Current Drug Targets. 13(13). 1676–1686. 27 indexed citations
20.
Lorenzo, Giuseppe Di, Giacomo Cartenì, Riccardo Autorino, et al.. (2009). Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer. Journal of Clinical Oncology. 27(27). 4469–4474. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tony Elliott Breakdown of academic impact, for papers by Guilhem Roubaud Breakdown of academic impact, for papers by Mario Eisenberger Breakdown of academic impact, for papers by Rosa Nadal Breakdown of academic impact, for papers by Teodoro Sava Breakdown of academic impact, for papers by Sebastian Rogenhofer Breakdown of academic impact, for papers by Carlo Messina Breakdown of academic impact, for papers by Remedios Penetrante Breakdown of academic impact, for papers by Damien Pouessel Breakdown of academic impact, for papers by Idris Tolgay Ocal
Rankless by CCL
2026